Cytotoxicity of rsu 1069 in spheroids and murine tumors
- 1 September 1987
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (9) , 1361-1366
- https://doi.org/10.1016/0360-3016(87)90230-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT)British Journal of Cancer, 1986
- Acute hypoxia in tumors: Implications for modifiers of radiation effectsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Experimental pharmacokinetics of rsu-1069 and its analogues: High tumor/plasma ratiosInternational Journal of Radiation Oncology*Biology*Physics, 1986
- The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumorInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Cell selection from a murine tumour using the fluorescent probe Hoechst 33342British Journal of Cancer, 1985
- RSU 1069, a 2-nitroimidazole containing an alkylating group: High efficiency as a radio- and chemosensitizer in vitro and in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Radiation sensitization and chemopotentiation: Rsu 1069, a compound more efficient than misonidazole in vitro and in vivoBritish Journal of Cancer, 1984
- Use of Hoechst 33342 for cell selection from multicell systems.Journal of Histochemistry & Cytochemistry, 1982
- A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouseBritish Journal of Cancer, 1976